By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Metabolon and Charles River Discovery Services are partnering to advance cancer research.

The deal, which was officially announced this week, leverages Metabolon's metabolomics technology with Charles River's preclinical oncology expertise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.